YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
YAP is a transcriptional coactivator of the Hippo signaling pathway that has largely been studied for its role in the regulation of organ size during development. Several studies have shown that YAP is upregulated in cancer cells, and more recently in the T regulatory (Treg) subset of CD4+ cells. Th...
Main Authors: | Andriana Lebid, Liam Chung, Drew M. Pardoll, Fan Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00580/full |
Similar Items
-
Regulation of localization and function of the transcriptional co-activator YAP by angiomotin
by: Susana Moleirinho, et al.
Published: (2017-05-01) -
CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
by: Huixian Xin, et al.
Published: (2022-06-01) -
Mask family proteins ANKHD1 and ANKRD17 regulate YAP nuclear import and stability
by: Clara Sidor, et al.
Published: (2019-10-01) -
YAP drives cutaneous squamous cell carcinoma formation and progression
by: Zoé Vincent-Mistiaen, et al.
Published: (2018-09-01) -
YAP and the Hippo pathway in pediatric cancer
by: Atif A. Ahmed, et al.
Published: (2017-05-01)